Home NDC 60505-3659-6 Sitagliptin and Metformin Hydrochloride
Product NDC 60505-3659
Requested package NDC 60505-3659-6
11-digit product format 605053659
Labeler code 60505
Product ID 60505-3659_36ef9eed-221e-a76c-c2a3-80ab897bac8a
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Sitagliptin and Metformin Hydrochloride
Dosage form TABLET, FILM COATED
Route ORAL
Labeler Apotex Corp.
Application ANDA202426
Marketing category ANDA
Marketing start 2026-05-28
Substance SITAGLIPTIN PHOSPHATE; METFORMIN HYDROCHLORIDE
Active strength 50; 1000 mg/1; mg/1
Pharmacologic classes Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A202426-001 SITAGLIPTIN AND METFORMIN HYDROCHLORIDE METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE 500MG;EQ 50MG BASE TABLET / ORAL AB 2026-04-30 A202426-002 SITAGLIPTIN AND METFORMIN HYDROCHLORIDE METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE 1GM;EQ 50MG BASE TABLET / ORAL AB 2026-04-30
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-10-15 13:18:30 2026-09 A202426-001 SITAGLIPTIN AND METFORMIN HYDROCHLORIDE 500MG;EQ 50MG BASE TABLET / ORAL AB 2026-04-30 c2088c7a36db…2026-10-15 13:18:30 2026-09 A202426-002 SITAGLIPTIN AND METFORMIN HYDROCHLORIDE 1GM;EQ 50MG BASE TABLET / ORAL AB 2026-04-30 c2088c7a36db…2026-09-14 22:38:34 2026-08 A202426-001 SITAGLIPTIN AND METFORMIN HYDROCHLORIDE 500MG;EQ 50MG BASE TABLET / ORAL AB 2026-04-30 84e616aacf4f…2026-09-14 22:38:34 2026-08 A202426-002 SITAGLIPTIN AND METFORMIN HYDROCHLORIDE 1GM;EQ 50MG BASE TABLET / ORAL AB 2026-04-30 84e616aacf4f…2026-08-18 06:07:40 2026-07 A202426-001 SITAGLIPTIN AND METFORMIN HYDROCHLORIDE 500MG;EQ 50MG BASE TABLET / ORAL AB 2026-04-30 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A202426-002 SITAGLIPTIN AND METFORMIN HYDROCHLORIDE 1GM;EQ 50MG BASE TABLET / ORAL AB 2026-04-30 caaa826d4ba7…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A202426-001 SITAGLIPTIN AND METFORMIN HYDROCHLORIDE 500MG;EQ 50MG BASE TABLET / ORAL AB 2026-04-30 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A202426-002 SITAGLIPTIN AND METFORMIN HYDROCHLORIDE 1GM;EQ 50MG BASE TABLET / ORAL AB 2026-04-30 a50c72e98297…
Observed Orange Book normalized TE history# Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Sitagliptin and Metformin Hydrochloride
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength SITAGLIPTIN PHOSPHATE 50 mg/1 METFORMIN HYDROCHLORIDE 1000 mg/1
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 60505-3659-6 Sitagliptin and Metformin Hydrochloride 60 in 1 BOTTLE TABLET, FILM COATED 60 1 60505-3659-7 Sitagliptin and Metformin Hydrochloride 180 in 1 BOTTLE TABLET, FILM COATED 180 1
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Sample Exclude flag Status 60505-3659-6 60505365906 60 TABLET, FILM COATED in 1 BOTTLE (60505-3659-6) 2026-05-28 No No Current